Abbott’s Absolute Pro Stent for Iliac Disease has gained FDA clearance. The product is designed for precise stent placement and Optimal Flexibility to Conform to Challenging Lesions.
Vascular
FDA Issues Guidance On TriVascular Ovation EndoGraft For Patients With Small Access Vessels And Small Aortic Anatomy
After granting approval for TriVascular to sell its Ovation Endograft in USA under Humanitarian Exemption, FDA now issues guidance for consumers.
Double Whammy For Cook With First Japanese Drug-Eluting Peripheral Stent And First Stent For SFA Indication
Cook’s Zilver PTX Becomes First SFA Stent and first Drug-Eluting Peripheral Stent
Vascutek Anaconda Field Safety Notice
Vascutek Field Safety Notice issued to ensure safe removal of the bifurcate delivery system when inserting Anaconda and Anaconda ONE-LOK™ AAA grafts.
Migration To Premium Priced Needlestick Injury Prevention Devices Will Drive Growth In European Vascular Access Device Market
Adherence to the EU Sharps Directive will result in adoption of premium priced products to prevent needlestick injury, according to Millennium Research Group.
No Long Guidewire, Less Bruising: FDA Clearance for AngioDynamics NeverTouch Direct™Procedure Kit For Use With the VenaCure EVLT® System
NeverTouch Direct Kit for treatment of Varicose Veins With Fewer Procedure Steps, has gained FDA clearance.
New Features In AngioDynamics DuraFlow™ 2 Chronic Hemodialysis Catheter
New chronic hemodialysis catheter from Angiodynamics provides additional configurations, and convenient packaging for inventory control and outpatient settings.
AngioDynamics Gains Scale And Technology With Navilyst Acquisition.
Vascular specialist AngioDynamics, has announced it has agreed to acquire Navilyst Medical in a transaction valued at $372 million.
Covidien’s CE Marked Revascularisation Device Now Approved for US Trial
Covidien’s Solitaire FR device has been accepted into US stroke trial on an investigational basis. Company financials look strong and sounds bullish about the forthcoming tax levy.
DURABILITY II “Long Stent” Study: One Year Data Presented at ISET 2012
Covidien’s Everflex system, designed to treat long vascular lesions with a single stent, is the subject of an extensive clinical study, interim results of which have been released. The stent is already approved for use in Europe.
CE Mark For “Bi-Directional Retrieval” Inferior Vena Cava Filter
Crux Biomedical has announced it has received CE mark approval for its revolutionary inferior vena cava filter with bi-directional retrieval.
CE Mark And Launch For Medtronic’s Endurant® II AAA Stent Graft System
Medtronic’s Endurant® II Stent Graft to repair Abdominal Aortic Aneurysms without open surgery.
FDA Likes “Chocolate”… PTA Balloon Catheter
TriReme Medical, Inc.has received 510(K) FDA approval to market its “Chocolate” PTA balloon catheter for the treatment of occluded peripheral arteries in the United States.
Angio-Seal Disputes: Kensey Nash And St. Jude Medical Agree To Mediation
Kensey Nash Corporation and St. Jude Medical will enter into non-binding mediation in an attempt to resolve disputes over royalty payments to Kensey Nash relating to the Angio-Seal vascular closure device, as well as other related claims.
90% Of Retrievable IVC Filters Not Retrieved According To Boston Researchers
Boston researchers have found that less than 10% of retrievable IVC filters were removed from patients, despite the fact that the indication for the filter placement was no longer present at discharge.
Abbott Trials Absorb™ Bioresorbable Vascular Scaffold Against Metallic Drug Eluting Stent
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company’s XIENCE PRIME™ Everolimus Eluting Coronary Stent System.